MolProbity: all-atom structure validation for macromolecular crystallography
For instance: people with obesity are more likely to develop type 2 diabetes people with obesity are at an increased riskof developing Alzheimers later in life people with type 2 diabetes are also more likely to develop Alzheimers disease Alzheimers disease is associated with insulin resistance in the brain, with some scientists referring to Alzheimers as type 3 diabetes obesity, type 2 diabetes, and Alzheimers all involve inflammation, and GLP-1 agonists have an anti-inflammatory effect studies in animal models of dementiahave shown that GLP-1 agonists can protect rats brains from damage
Hypothyroidism slows metabolism, making weight management particularly challenging even with optimal levothyroxine replacement
And our current thinking about obesity, and one of the components of the disease of obesity, is that some individuals although they all have GLP-1 and these other gut hormones, amylin, glucagon, GIP, that's what they're called that signal, for some reason, is not getting to the brain in ample amounts to tell the individual to feel full, satiated, and stop eating
Diabetes is an endocrine disorder, and the endocrine system coordinates a delicate hormonal interplay
Safety Considerations and Provider-Guided Individualization Individual factors including skin sensitivity, previous injection experience, anticoagulation therapy, and tissue characteristics influence optimal site selection
